Lifecare ASA

Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST

Lifecare ASA will publish its Q2 2025 results on Wednesday, 20 August 2025, at

07:00 CEST.

The company invites shareholders, investors, and other stakeholders to the

presentation of the second quarter results the same day at 10.45 CEST, to be

held at Scandic Flesland Airport Hotel, Bergen, Norway, in connection with the

event Vestland på Børs.

The results will be presented in English via a live webcast, followed by a Q&A

session. Participants will be able to submit questions online throughout the

webcast.

The webcast will be available at

https://lifecare.no/investor/reports-presentations/ and can also be accessed

here (https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20250820_14).

A recording of the webcast will be made available on the company's website

shortly after the event.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring ("CGM") systems to market.

Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor

technology is suitable for identifying and monitoring the occurrence of a wide

range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

AI Terminal